NYC Tech News for the week ending 7/11 including the NYC startup fundings, NYC startup exits, and NYC Tech events including news for Butler Hospitality, CALA, Kindbody, and much more…
The notable startup fundings for the week ending 7/10/20 featuring funding details for Perfect Day, Taulia, Truepill, and much much more.
The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 7/10/2020 featuring funding details for Parade and much more.
If you are in need of a job or customers, every single one of these companies just raised hundreds of millions of dollars. Everything you need to need to know about the largest global startup funding rounds of Q2 2020; broken down by industry, stage, investors, and more…
Mike Edelhart of Social Starts walks us through some observations on how COVID-19 has impacted trends from a VC’s perspective.
Some “rules of thumb” for establishing at least an advisory board well before you sign up investors or ship your first product.
CALA is a full-stack managed solution for people looking to launch their own fashion and clothing line. Design, sourcing, sales, and fulfillment are all handled on the platform, which is also supported by a network of experts. Newbie fashion entrepreneurs are often overwhelmed with all the moving parts and CALA makes it easy all for a monthly subscription fee and percentage of sales. CEO Andrew Wyatt shes some light about the company’s traction which includes clients like NFL player Travis Kelce, rapper A$AP Ferg, and model Tatiana Ringsby. The company, founded in 2016, also just closed its seed round from investors that include Maersk Growth and Real Ventures.
The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 7/9/2020 featuring funding details for Kindbody, SIMULATE, and much more.
The average time to get a drug to market, crossing FDA hurdles, is 12 years and costs in excess of $1B. And in those twelve years, there is animal testing, human trials, and dozens of other steps that a company needs to go through. TARA Biosystems has found a way to generate human tissue OUTSIDE of the body that can be used in the drug development process to test safety and effectiveness without harming animals or risking human life. CEO Misti Ushio shares some insight on the potential of in vitro biology for drug development, TARA Biosystem’s different lines of business, and recent funding round from investors that include OMX Ventures, Merieux Equity Partners, Partnership Fund for New York City, Trancos Ventures, DEFTA Partners, and Tachyon Ventures.
The world was moving towards direct-to-consumer anyway, COVID just accelerated it because people got forced into new behaviors. Now that people have had a taste, it’s going to be very hard to “wean them off” of the convenience, price power, and enjoyment of e-commerce buying. It doesn’t mean that people aren’t going to go to stores anymore, it just means that a lot of consumers have added e-commerce into the mix or that e-commerce is now a bigger percentage of their overall activity. Find out what you should be doing to capitalize on this shift.